Soleus Capital Master Fund, L.P. 13D and 13G filings for Organogenesis Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:35 pm Purchase | 2024-09-30 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 11,839,876 8.900% | 2,876,876 (+32.10%) | Filing |
| 2024-02-02 09:54 am Purchase | 2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 8,963,000 6.800% | 1,599,937 (+21.73%) | Filing |
| 2023-02-14 08:22 am Purchase | 2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 7,363,063 5.600% | 737,000 (+11.12%) | Filing |
| 2022-10-13 5:01 pm Purchase | 2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 6,626,063 5.100% | 6,626,063 (New Position) | Filing |